Adherencia farmacológica y prevención secundaria cardiovascular: una de las principales barreras en el tratamiento de la enfermedad ateroesclerótica: posición del Departamento de Prevención Cardiovascular de SOCHICAR en el uso de la polipíldora en prevención secundaria / Adherence to pharmacologic treatment in secondary prevention of cardiovascular disease
Rev. chil. cardiol
;
35(3): 270-282, 2016. tab
Artigo
em Espanhol
| LILACS
| ID: biblio-844301
ABSTRACT
This paper outlines the position of the Department of Cardiovascular Prevention from the Chilean Society of Cardiology regarding the use of the "polypill". The international and local evidence regarding the benefits of the polypill compared to conventional therapy is reviewed. The benefits and some limitations of the polypill are outlined, along with cost-effective considerations. The increased adherence to treatment and the better clinical results of this strategy are put forward. The used of the polypill in different groups of subjects, especially those recovered from a recent myocardial in-farction, is recommended for individual patients and in Chilean cardiovascular prevention programs from the Ministry of Health.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Fármacos Cardiovasculares
/
Doenças Cardiovasculares
/
Aterosclerose
/
Adesão à Medicação
Tipo de estudo:
Estudo de etiologia
Limite:
Humanos
País/Região como assunto:
América do Sul
/
Chile
Idioma:
Espanhol
Revista:
Rev. chil. cardiol
Assunto da revista:
Cardiologia
Ano de publicação:
2016
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Sociedad Chilena de Cardiología y Cirugía Cardiovascular/CL
Similares
MEDLINE
...
LILACS
LIS